Next Investors logo grey

Abundant releases strong commercial update

Published 10-MAY-2018 10:20 A.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Abundant Produce (ASX:ABT) has released a highly promising commercial report, including an update on its wholly owned subsidiary, Abundant Natural Health (ANH).

ANH has signed its first ambassadors, Australian international women football players Lisa De Vanna, Chloe Logarzo and Caitlin Foord.

The three signings will promote ANH’s Cucumber Infusion Magnesium Sport Spray and Ache Relief Gel for the next 12 months.

ANH CEO Shanan Birkin spoke on the update, “This impressive trio will work together to promote our products over the next year.

“As arguably three of the greatest female footballers in the world, we are thrilled to have Lisa, Chloe and Caitlin representing our business. They are formidable role models that reflect our company’s culture of supporting women in all forms of life,” she said.

The Magnesium Sport Spray and Ache Relief Gel are both infused with ANH’s cucumber juice, which are high in an array of acids. These acids aid skin penetration enabling the company’s 99.9% pure, highly concentrated magnesium to quickly penetrate the skin, delivering fast relief.

Birkin added, “Importantly at Abundant we are proud to promote gender balance and equality in sport, business and family and look forward to working with Lisa, Chloe and Caitlin over the next year.

“Our magnesium products are receiving rave reviews from the sporting community and associated professionals such as physiotherapists.”

However this remains a specualtive play and as such any investment decision should be made with caution and professional financial advice should be sought.

ANH signs deal with Busan University

ANH also announced a new deal with Busan University in South Korea.

The deal is ANH’s fourth university collaboration, having previously reached agreements with The University of Sydney, The University of New South Wales and Chonnam National University in South Korea.

Abundant Produce CEO Tony Crimmins spoke on the contract news, “We are looking at faster ways to propel magnesium through the skin barrier to deliver its benefits direct to the muscles requiring attention.

“By using ANH’s cucumber juice, derived from our pregnant cucumbers which are full of life giving chemicals, Busan University will make high level lactic acid and ultimately deliver much needed natural magnesium actives to our customers in their purest form.”

ABT moves its corporate house

ABT informed shareholders that it has moved its headquarters from Pyrmont to a larger 600 sqm production and office facility in Chatswood.

Under the move, the company will bring its active ingredient production under one roof with space to expand.

Abundant produce progress

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.